MT 1585 Erucic acid, [3H]- Click here for Typical Certificate of Analysis |
|
| (cis-13-Docosenoic acid, [3H]-) | |
| CH3(CH2)7CH=CH(CH2)11COOH | |
MORpure™ HPLC purified, Delivered ≥ 97% pure with dated HPLC radiochromatogram |
|
| Ethanol:water (1:1) solution, 1 mCi/ml - This material requires a strong PVC overpack for shipment. See details. | |
| > 40 Ci(1.48 TBq)/mmol | 50 μCi (1.85 MBq) $1160 |
| NextGen V-Vial - shipped on dry ice | 250 μCi (9.25 MBq) $1970 |
| M.W. 338.6 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MC 2018 Erucic acid, [14-14C]- |
|
| (cis-13-Docosenoic acid, [14-14C]-) | |
| CH3(CH2)7CH=CH(CH2)11COOH | |
HPLC purified, Delivered ≥ 95% pure with dated HPLC radiochromatogram |
|
| Ethanol solution under argon, 100 µCi/ml - This material requires a strong PVC overpack for shipment. See details. | |
| > 50 mCi(1.85 GBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial - shipped on dry ice | |
| M.W. 338.6 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
